These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19944966)

  • 21. Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial.
    Salazar AM; Erlich RB; Mark A; Bhardwaj N; Herberman RB
    Cancer Immunol Res; 2014 Aug; 2(8):720-4. PubMed ID: 24801836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly ICLC enhances the antimalarial activity of chloroquine against multidrug-resistant Plasmodium yoelii nigeriensis in mice.
    Awasthi A; Mehrotra S; Bhakuni V; Dutta GP; Levy HB; Maheshwari RK
    J Interferon Cytokine Res; 1997 Jul; 17(7):419-23. PubMed ID: 9243375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of recurrent laryngeal papillomatosis with an artificial interferon inducer (poly ICLC).
    Leventhal BG; Kashima H; Levine AS; Levy HB
    J Pediatr; 1981 Oct; 99(4):614-6. PubMed ID: 7277106
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunotherapeutic approach with oligodeoxynucleotides containing CpG motifs (CpG-ODN) in malignant glioma.
    Ursu R; Carpentier AF
    Adv Exp Med Biol; 2012; 746():95-108. PubMed ID: 22639162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of polyinosinic-polycytidylic and poly-L-lysine in metastatic breast cancer.
    Theriault RL; Hortobagyi GN; Buzdar AU; Levy HB; Hersh EM
    Cancer Treat Rep; 1986 Nov; 70(11):1341-2. PubMed ID: 3768878
    [No Abstract]   [Full Text] [Related]  

  • 26. Poly-ICLC, a multi-functional immune modulator for treating cancer.
    Sultan H; Salazar AM; Celis E
    Semin Immunol; 2020 Jun; 49():101414. PubMed ID: 33011064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon induction and therapy of brain tumors in rats by poly(ICLC).
    Machida H; Takezawa J; Kuninaka A; Yoshino H; Nakamura O; Takakura K
    Microbiol Immunol; 1982; 26(4):353-8. PubMed ID: 6180284
    [No Abstract]   [Full Text] [Related]  

  • 28. Fighting infection using immunomodulatory agents.
    Masihi KN
    Expert Opin Biol Ther; 2001 Jul; 1(4):641-53. PubMed ID: 11727500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of an immunotherapeutic protocol with poly(I,C)-LC.
    Talmadge JE; Hartmann D
    J Biol Response Mod; 1985 Oct; 4(5):484-9. PubMed ID: 4078594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortisol induction by poly ICLC: implications for clinical trials of interferon.
    Bever CT; McFarland HF; Levy HB; McFarlin DE
    Ann Neurol; 1988 Feb; 23(2):196-9. PubMed ID: 2454067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Killing of Leishmania donovani amastigotes by poly ICLC in hamsters.
    Bhakuni V; Singha UK; Dutta GP; Levy HB; Maheshwari RK
    J Interferon Cytokine Res; 1996 Apr; 16(4):321-5. PubMed ID: 9162526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells.
    Smith KE; Fritzell S; Badn W; Eberstål S; Janelidze S; Visse E; Darabi A; Siesjö P
    Int J Cancer; 2009 Feb; 124(3):630-7. PubMed ID: 18972433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of a modified polyinosinic acid--polycytidylic acid complex against herpes simplex keratitis in monkeys (author's transl)].
    Teranishi H
    Nippon Ganka Gakkai Zasshi; 1980 Sep; 84(9):1198-204. PubMed ID: 7223554
    [No Abstract]   [Full Text] [Related]  

  • 34. A preliminary trial of poly(I,C)-LC in multiple sclerosis.
    McFarlin DE; Bever CT; Salazar AM; Levy HB
    J Biol Response Mod; 1985 Oct; 4(5):544-8. PubMed ID: 2416885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of intracranial alphavirus infections in mice by a combination of specific antibodies and an interferon inducer.
    Coppenhaver DH; Singh IP; Sarzotti M; Levy HB; Baron S
    Am J Trop Med Hyg; 1995 Jan; 52(1):34-40. PubMed ID: 7531956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical treatment of vaccinia virus infection with an interferon inducer in rabbits.
    Levy HB; Lvovsky E
    J Infect Dis; 1978 Jan; 137(1):78-81. PubMed ID: 624854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator.
    Peters CJ; Reynolds JA; Slone TW; Jones DE; Stephen EL
    Antiviral Res; 1986 Aug; 6(5):285-97. PubMed ID: 2429616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human autologous in vitro models of glioma immunogene therapy using B7-2, GM-CSF, and IL12.
    Parney IF; Farr-Jones MA; Kane K; Chang LJ; Petruk KC
    Can J Neurol Sci; 2002 Aug; 29(3):267-75. PubMed ID: 12195617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of interferon on rabies infection of animals.
    Baer GM
    Tex Rep Biol Med; 1981-1982; 41():526-31. PubMed ID: 6189218
    [No Abstract]   [Full Text] [Related]  

  • 40. Preliminary trial of poly ICLC in chronic progressive multiple sclerosis.
    Bever CT; Salazar AM; Neely E; Ferraraccio BE; Rose JW; McFarland HF; Levy HB; McFarlin DE
    Neurology; 1986 Apr; 36(4):494-8. PubMed ID: 3960323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.